INDP

$1.70-0.06 (-3.41%)

Market ClosedAs of Mar 20, 8:00 PM UTC

Indaptus Therapeutics, Inc., a clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products.

Overview Intraday AnalysisPRO IntelligencePRO Ask AIPRO TranscriptsPRO StatementsPRO

Recent News

MT Newswires

Wall Street Set to Open Higher Friday; Nonfarm Payrolls Fall Well Short of Forecasts

US stocks look set to open higher in Friday's trading session as investors parse key jobs data showi

Positive press. Headlines skewed toward growth and analyst upgrades.